Dilated Cardiomyopathy (DCM) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Dilated cardiomyopathy (DCM) is a pathological condition of the heart characterized by the dilation and enlargement of one or both ventricles, along with impaired contractility, as defined by a left ventricular ejection fraction (LVEF) of less than 40%. The condition can be classified as primary or secondary, with primary DCM being of idiopathic origin and diagnosed after excluding secondary causes. Patients with DCM typically have systolic dysfunction and may or may not exhibit overt symptoms of heart failure. DCM is often progressive, leading to heart failure and death. Without a transplant, survival rates for patients with DCM are poor. The etiology of DCM is diverse, with the most common cause being idiopathy, and may also have a familial or genetic predisposition. Secondary causes include infectious myocarditis, ischemic disease, hypertension, medication-induced alcohol abuse, HIV, peripartum cardiomyopathy, or infiltrative disease. The New York Heart Association (NYHA) class...